Neuronal and axonal loss in normal-appearing gray matter and subpial lesions in multiple sclerosis
- PMID: 25853695
- DOI: 10.1097/NEN.0000000000000189
Neuronal and axonal loss in normal-appearing gray matter and subpial lesions in multiple sclerosis
Abstract
Multiple sclerosis (MS) is a demyelinating and neurodegenerative disease of the CNS. Multiple sclerosis lesions include significant demyelination of the gray matter, which is thought to be a major contributor to both physical and cognitive impairment. Subpial (Type III) lesions are the most common demyelinated cortical lesions. We investigated neurodegenerative features of subpial lesions in cerebral cortex samples from 11 patients with MS and 6 nondemented non-MS controls. There were no significant differences in neuron and axon density between normally myelinated normal-appearing gray matter (NAGM) and Type III MS lesions. Neurons were 11.2% smaller in Type III lesions than in NAGM in the cingulate cortex only; Type III lesions contained 25.4% fewer NeuN-positive neurons compared with control cortex. Neurons in MS NAGM were 13.6% smaller than those in control cortex. Finally, the same regions, immunostained with anti-SMI312 antibodies, showed reduced axon densities in Type III lesions (-31.4%) and NAGM (-33.0%) compared with controls. In conclusion, both NAGM and Type III lesions showed neurodegenerative changes, but they had no consistent differences in neuronal and axonal alterations. This suggests that neurodegeneration in the cerebral cortex of patients with MS may be independent of cortical demyelination.
Similar articles
-
Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter.J Neuropathol Exp Neurol. 2009 May;68(5):489-502. doi: 10.1097/NEN.0b013e3181a19a5a. J Neuropathol Exp Neurol. 2009. PMID: 19525897
-
Ultra-high field MTR and qR2* differentiates subpial cortical lesions from normal-appearing gray matter in multiple sclerosis.Mult Scler. 2016 Sep;22(10):1306-14. doi: 10.1177/1352458515620499. Epub 2015 Dec 16. Mult Scler. 2016. PMID: 26672996
-
High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis.Brain. 2010 Mar;133(Pt 3):858-67. doi: 10.1093/brain/awp335. Epub 2010 Jan 31. Brain. 2010. PMID: 20123726
-
[Gray matter lesions and cognitive impairment in multiple sclerosis].Rinsho Shinkeigaku. 2014;54(12):1060-2. doi: 10.5692/clinicalneurol.54.1060. Rinsho Shinkeigaku. 2014. PMID: 25672709 Review. Japanese.
-
[Cortical gray matter lesions in multiple sclerosis].Brain Nerve. 2015 Apr;67(4):497-504. doi: 10.11477/mf.1416200166. Brain Nerve. 2015. PMID: 25846598 Review. Japanese.
Cited by
-
Regional grey matter microstructural changes and volume loss according to disease duration in multiple sclerosis patients.Sci Rep. 2021 Aug 19;11(1):16805. doi: 10.1038/s41598-021-96132-x. Sci Rep. 2021. PMID: 34413373 Free PMC article.
-
C1ql1 expression in oligodendrocyte progenitor cells promotes oligodendrocyte differentiation.FEBS J. 2025 Jan;292(1):52-74. doi: 10.1111/febs.17256. Epub 2024 Sep 11. FEBS J. 2025. PMID: 39257292
-
"Ependymal-in" Gradient of Thalamic Damage in Progressive Multiple Sclerosis.Ann Neurol. 2022 Oct;92(4):670-685. doi: 10.1002/ana.26448. Epub 2022 Jul 30. Ann Neurol. 2022. PMID: 35748636 Free PMC article.
-
The relevance of multiple sclerosis cortical lesions on cortical thinning and their clinical impact as assessed by 7.0-T MRI.J Neurol. 2021 Jul;268(7):2473-2481. doi: 10.1007/s00415-021-10400-4. Epub 2021 Feb 1. J Neurol. 2021. PMID: 33523256
-
CSF parvalbumin levels reflect interneuron loss linked with cortical pathology in multiple sclerosis.Ann Clin Transl Neurol. 2021 Mar;8(3):534-547. doi: 10.1002/acn3.51298. Epub 2021 Jan 23. Ann Clin Transl Neurol. 2021. PMID: 33484486 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical